InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: zalicuslicious post# 4218

Friday, 09/06/2019 7:34:53 PM

Friday, September 06, 2019 7:34:53 PM

Post# of 5001
I don’t think so Zal, the Blair report is fresh and was nearly 60 pages with comparatives. There has been a steady stream of buying since that report and I think it was oversold and hyper shorted to begin with.

Not sure what could be leaked because trials are double blinded. Not even the clinics running the trials know whether patients were given placebo or AV-101.

I guess other milestones could be coming but the Elevate trial is what everyone is waiting on. From risk reward perspective it is not many times you will get a chance to buy a stock this cheap based on all the milestones it has hit. That includes patents, fast track designation, safety profiles and the addition of 2 new potential blockbuster drugs in the pipeline. With data seemingly so close investors were bound to be attracted. Blair made a 1000 percent share price increase call.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News